Long-term infusion of anti-GD2 antibody ch14.18/CHO in combination with interleukin-2 (IL2) activity and efficacy in high-risk relapsed/refractory neuroblastoma patients.
暂无分享，去创建一个
I. Yaniv | S. Endres | D. Seidel | R. Ladenstein | A. Garaventa | H. Lode | D. Valteau‐Couanet | N. Siebert | H. Loibner | E. Janzek | V. Castel | K. Ehlert | S. Kietz | J. Gray | Christin Eger | C. Jensen | Madlen Juettner | Ina Mueller | L. Pill